Reconstruction of Severe Forearm Osteomyelitis
Hand Clinics · 2026
DOI: 10.1016/j.hcl.2026.06.010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Hand Clinics, 2026. Verfasst von Bruno Battiston und 2 weiteren Autor:innen. Beteiligte Einrichtung: UOC Traumatology and Hand Surgery Department, CTO Hospital, Turin, Italy. Electronic address: battistonbruno@gmail.com. Hauptthemen laut MEDLINE: Osteomyelitis, Forearm, Plastic Surgery Procedures. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
This article reviews the surgical management of severe chronic forearm osteomyelitis using free vascularized fibular flaps (VFFs), with or without the one-bone forearm (OBF) technique. Based on a 22 patient retrospective series, outcomes show that VFF enables reliable reconstruction of extensive bone and soft tissue defects following radical debridement. In selected cases, OBF offers a salvage solution for both radius and ulna bone loss. The approach led to high infection control rates, bone healing, and functional recovery. Microsurgical reconstruction, particularly using VFF, remains the gold standard for complex forearm infections, restoring structural stability and enabling meaningful upper limb function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- UOC Traumatology and Hand Surgery Department, CTO Hospital, Turin, Italy. Electronic address: battistonbruno@gmail.com.
- UOC Traumatology and Hand Surgery Department, CTO Hospital, Turin, Italy.
Zitieren
APA
Battiston, B., Teodori, J., & Crosio, A. (2026). Reconstruction of Severe Forearm Osteomyelitis. Hand Clinics. https://doi.org/10.1016/j.hcl.2026.06.010
Vancouver
Battiston B, Teodori J, Crosio A. Reconstruction of Severe Forearm Osteomyelitis. Hand Clinics. 2026. doi:10.1016/j.hcl.2026.06.010
BibTeX
@article{Battiston2026,
author = {Battiston, Bruno and Teodori, Julien and Crosio, Alessandro},
title = {Reconstruction of Severe Forearm Osteomyelitis},
journal = {Hand Clinics},
year = {2026},
doi = {10.1016/j.hcl.2026.06.010}
}
EUVIMED